Turn Therapeutics Inc.
TTRX
$6.93
$0.111.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -195.59% | 186.38% | -185.74% | -- | 15.64% |
| Total Depreciation and Amortization | 16.94% | 14.52% | 13.22% | -- | 7.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.32% | -4,659.21% | -84.15% | -- | 909.29% |
| Change in Net Operating Assets | -139.43% | 535.81% | 4,194.22% | -- | -550.15% |
| Cash from Operations | -447.74% | -173.24% | -56.42% | -43.89% | -7.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -302.56% | -106.44% | -- | -- |
| Cash from Investing | 23.27% | -302.56% | -106.44% | 34.02% | 34.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.20% | 508.52% | 83.80% | -- | 550.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 680.14% | 508.52% | 83.80% | 925.81% | 550.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 777.36% | 2,250.84% | 12.89% | 882.91% | 572.97% |